Welcome to our dedicated page for Federated Hermes SEC filings (Ticker: FHI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Federated Hermes, Inc. (NYSE: FHI) SEC filings page provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Federated Hermes is a Pennsylvania-incorporated global active investment manager, and its filings document material events, financial results and significant agreements affecting the business.
Among the most relevant documents for FHI are its current reports on Form 8-K. Recent 8-K filings include earnings releases reporting quarterly financial and operating results, with details on revenue, operating expenses, nonoperating income, net income and earnings per share. These filings also describe how revenue is derived from money market, equity, fixed-income and alternative/private markets and multi-asset assets, and provide context on assets under management across these categories.
Other 8-Ks cover material definitive agreements and strategic transactions, such as the Sale and Purchase Agreement under which Federated Hermes agreed to acquire an 80% interest in FCP Fund Manager, L.P., a U.S. real estate investment manager. The related filing outlines the structure of the transaction, purchase price components, conditions to closing and governance arrangements, offering insight into how Federated Hermes is expanding its private markets and real estate capabilities.
Federated Hermes also uses 8-K filings to disclose leadership and governance changes, including executive succession at the Federated Advisory Companies and Federated Securities Corp., and changes in board roles. These filings provide formal notice of transitions in key management positions and board composition.
On Stock Titan, FHI filings are updated as they become available from EDGAR. AI-powered tools can help summarize lengthy documents such as earnings releases and transaction-related exhibits, highlighting key figures, asset mix information and major contractual terms. Users can review Forms 10-K and 10-Q for comprehensive annual and quarterly reporting, and Forms 8-K for event-driven updates, while AI-generated insights assist in understanding how developments in assets under management, revenue composition, expenses and strategic deals may shape Federated Hermes’ business profile over time.
Federated Hermes, Inc. (FHI) reported a Form 4 for a vice president who is also a director. On 11/18/2025, the insider acquired 18,000 shares of Class B common stock at $3 per share, and on 11/19/2025 sold 7,638 shares at a weighted average price of $47.8654. The filing explains that the sale was made to cover tax obligations arising from the vesting of restricted shares. After these transactions, the insider directly owned 463,615 Class B shares, with additional indirect holdings of 40,000 shares through Rosewood Limited Partnership and 30,582 shares through a 401(k) plan.
Federated Hermes, Inc. (FHI) reported insider activity by its VP and Chief Compliance Officer on a Form 4. On 11/18/2025, the officer acquired 3,000 shares of Class B common stock. On 11/19/2025, the officer sold 707 shares of Class B common stock at a weighted average price of $47.8556 per share, in 18 transactions at prices between $47.70 and $48.24. The sale was made to cover tax obligations arising from the vesting of restricted shares. After these transactions, the officer directly owns 31,889 shares of Class B common stock.
Federated Hermes, Inc. (FHI) vice president reported recent transactions in Class B common stock. On 11/18/2025, the reporting person acquired 18,000 shares, increasing their beneficial holdings to 333,930 shares directly owned. On 11/19/2025, they sold 6,496 shares at a weighted average price of $47.8481, leaving 327,434 shares beneficially owned.
According to the footnotes, the sale represents shares sold to cover tax obligations from the vesting of restricted stock. The price reflects 43 separate sales transactions within a range of $47.585 to $48.24, and full trade-by-trade details are available on request.
Federated Hermes, Inc. (FHI) filed a Form 4 reporting insider equity transactions by a vice president. On 11/18/2025, the officer acquired 18,000 shares of Class B common stock at $3 per share, increasing direct beneficial ownership to 155,577 shares. On 11/19/2025, the officer sold 3,721 Class B shares at a weighted average price of $47.8429 per share, leaving 151,856 Class B shares directly owned. The company notes that the sale was made to cover tax obligations arising from the vesting of restricted stock, and that the sale price reflects 31 separate trades within a narrow price range.
Federated Hermes, Inc. (FHI) reported an insider share purchase by its Chairman, President and CEO, who is also a director. On 11/18/2025, the executive acquired 18,000 shares of Class B common stock in a transaction reported on Form 4 at a price of $3 per share. Following this purchase, the executive directly owns 444,288 shares of Federated Hermes Class B common stock. The filing indicates the transaction was reported by a single reporting person and includes a reference to an existing Power of Attorney for signing the form.
Federated Hermes, Inc. (FHI) reported an insider share purchase by its VP, CFO & Treasurer, who is also a director. On 11/18/2025, the reporting person acquired 18,000 shares of Class B common stock at $3 per share. After this transaction, the insider directly beneficially owns 592,948 Class B shares, with additional indirect holdings reported through several trusts, a 401(k) plan, a spouse, and related entities.
Federated Hermes (FHI) insider Peter J. Germain filed a Form 144 notice to sell up to 6,856 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $328,093.19. These shares come from restricted stock that vested under a registered plan on 11/19/2025, with services rendered listed as the form of payment.
The notice states that 77,537,867 shares of the issuer’s stock are outstanding. Over the prior three months, Germain also sold 5,000 Class B common/ordinary shares on 11/07/2025 for gross proceeds of $246,121. The form includes a representation that the seller is not aware of undisclosed material adverse information about the issuer.
A holder of FHI common stock filed a Form 144 notice to potentially sell 999 shares. The planned sale would be executed through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of 47,824.53 for the shares listed in the notice. The form reports that there are 77,537,867 shares of the issuer’s common stock outstanding.
The securities to be sold are common shares acquired on 11/19/2025 through restricted stock vesting under a registered plan, with services rendered identified as the form of payment. Form 144 also includes a representation by the seller that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
A holder of Federated Hermes (FHI) stock has filed a Form 144 to sell 707 shares of common stock through Morgan Stanley Smith Barney LLC on or about 11/19/2025 on the NYSE. The filing lists an aggregate market value of $33,833.91 for these shares and notes that 77,537,867 shares of this class were outstanding. The securities being sold were acquired on 11/19/2025 as restricted stock vesting under a registered plan, with the consideration described as services rendered. The signer represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
A shareholder of FHI has filed a Form 144 notice to sell 1,249 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 11/19/2025. The filing lists an aggregate market value of $59,765.52 for the proposed sale and notes that 77,537,867 shares of this class were outstanding at the time of the notice. The shares to be sold came from restricted stock vesting under a registered plan on 11/19/2025, received from the issuer as compensation for services rendered.